Agenda

7:30 – 8:15 am Registration Check-in & Networking Breakfast
8:15 – 8:30 am Welcome & Chairman’s 2015 Year in Review
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures
8:30 – 9:10 am Drug Delivery Company Showcase
Co-Moderated By:
Dr. Rafiq Hasan, VP & Global Head, Ophthalmology – Bayer Health Care
Thomas F. Zioncheck, PhD, Senior Director, Business Development – Genentech

8:30-8:38 – Ocular Therapeutix – Amar Sawhney, PhD, Chairman, President & CEO
8:38-8:46 – ForSight VISION5 – Anne Brody Rubin, VP, Marketing
8:46-8:54 – Envisia Therapeutics – Benjamin Yerxa, PhD, Co-Founder & President
8:54-9:02 – Mati Therapeutics – Robert Butchofsky, Founder & CEO
9:02-9:10 – GrayBug – Jeffrey L. Cleland, PhD, Interim CEO

9:10 – 10:14 am Device & Diagnostics Company Showcase
Co-Moderated By:
Andrew Chang, General Manger & VP, US Surgical – Valeant/Bausch+Lomb
Patrick T. Johnson, PhD, VP, Business Development – Allergan

9:10-9:18 – Transcend Medical – Sean Ianchulev, MD, MPH, CMO & VP, Medical Affairs & Business Development
9:18-9:26 – AcuFocus – Nick Tarantino, OD, Chief Global Clinical Research & Regulatory Affairs Officer
9:26-9:34 – ReVision Optics – John T. Kilcoyne, President & CEO
9:34-9:42 – Avedro – David Muller, PhD, President & CEO
9:42-9:50 – ClarVista Medical – Paul McLean, President & CEO
9:50-9:58 – Mynosys Cellular Devices – John Hendrick, President & CEO
9:58-10:06 – PowerVision – Barry Cheskin, Co-Founder, President & CEO
10:06-10:14 – RPS Diagnostics – Robert P. Sambursky, MD, Founder, President & CEO

10:14 – 10:45 am Morning Refreshment & Networking Break
10:45 am – 12:29 pm BioPharma Company Showcase
Co-Moderated By:
Kate Benedict, CPA, VP, US Pharmaceutical Sales – Alcon
Dirk Sauer, PhD, Global Head, Retina Development Franchise – Novartis Pharma AG

10:45-10:53 – Allegro Ophthalmics, LLC – Vicken Karageozian, MD, CTO & Co-Founder
10:53-11:01 – Applied Genetic Technologies Corporation (AGTC) – Mark Shearman, MD, PhD, CSO
11:01-11:09 – Vision Medicines – Chris Varma, PhD, Chairman & CEO
11:09-11:17 – Inotek Pharmaceuticals – David P. Southwell, President & CEO
11:17-11:25 – Eleven Biotherapeutics – Abbie C. Celniker, PhD, President & CEO
11:25-11:33 – Aura Biosciences – Elisabet de los Pinos, PhD, Founder & CEO
11:33-11:41 – Translatum Medicus, Inc. – Shelley Boyd, MD, President & CSO
11:41-11:49 – Acucela, Inc. – Ryo Kubota, MD, PhD, Chairman, President & CEO
11:49-11:57 – Ocata Therapeutics – Eddy Anglade, MD, Chief Medical Officer
11:57-12:05 – Circadian Technologies (Opthea) – Megan Baldwin, PhD, CEO & Managing Director
12:05-12:13 – Iconic Therapeutics – William L. Greene, MD, CEO
12:13-12:21 – PanOptica – Paul Chaney, Co-Founder, President & CEO
12:21-12:29 – ONL Therapeutics – John Freshley, President & CEO

12:29 – 12:35 pm Digital Ophthalmology Sector Overview
Michelle Snyder, Chief Marketing Officer – Welltok
12:35 – 1:00 pm Digital Ophthalmology Showcase
Moderated By:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners

12:35-12:40 – Gobiquity – Andrew Burns, CEO
12:40-12:45 – Amblyotech – Joseph Koziak, CEO
12:45-12:50 – DigiSight Technologies – Doug Foster, CEO
12:50-12:55 – MDbackline, LLC – John A. Hovanesian, MD, FACS, Founder
12:55-1:00 – ALPHAEON – Robert E. Grant, CEO

1:00 pm Lunch Commences
1:30 – 1:55 pm OIS Innovation Award Presentation
1:55 – 2:15 pm Plenary Keynote
Brent Saunders, President & CEO – Allergan
2:15 pm Lunch Concludes
2:15 – 2:22 pm Ophthalmic Innovation 2015 – “A View from the AAO”
David W. Parke, II, MD, CEO – American Academy of Ophthalmology (AAO)
2:22 – 2:30 pm Ophthalmic Innovation 2015 – “A View from the NEI”
Paul A. Sieving, MD, PhD, Director, National Eye Institute (NEI) – National Institutes of Health (NIH)
2:30 – 2:50 pm Alcon – Google Innovation: Visions of Ophthalmology in 2020
Moderated By:
William J. Link, PhD, Managing Director – Versant Ventures

Panel Participants:
Laurent Attias, Head, Strategy, BD&L & Market Access – Alcon
Franck Leveiller, PhD, Surgical R&D Franchise Head – Alcon

2:50 – 3:20 pm Protecting & Monetizing IP – A Primer for Early Stage Entrepreneurs
Moderated By:
Casey McGlynn, Partner – Wilson, Sonsini, Goodrich & Rosati

Panel Participants:
Mark S. Blumenkranz, MD, Director, Byers Eye Institute – Stanford
Richard L. Lindstrom, MD, Founder & Attending Surgeon – Minnesota Eye Consultants
John K. Shimmick, Patent Attorney – Wilson, Sonsini, Goodrich & Rosati
Reza Zadno, PhD, Advisor, Novartis Fund & Executive in Residence – InterWest Partners

3:20 – 3:40 pm Afternoon Refreshment & Networking Break
3:40 – 3:50 pm Private Funding Trends Presentation
Jonathan Norris, Managing Director – SVB
3:50 – 4:00 pm A View of the Public Ophthalmology Market & Exit Trends
Joseph Gilliam, Managing Director, Healthcare Investment Banking – J.P. Morgan
4:00 – 4:50 pm Public Device & BioPharma Ophthalmology Company Showcase
Moderated By:
Scott Beardsley, Partner – Novo Ventures US

4:00-4:10 – Aerie Pharmaceuticals – Vince Anido, Jr., PhD, CEO & Chairman
4:10-4:20 – Ophthotech Corporation – David Guyer, MD, CEO & Chairman
4:20-4:30 – Spark Therapeutics – Jeffrey D. Marrazzo, Co-Founder & CEO
4:30-4:40 – Second Sight Medical Products, Inc. – Robert Greenberg, MD, Chairman
4:40-4:50 – Alimera – Dan Myers, Co-Founder, President & CEO

4:50 – 5:20 pm Thinking About Market Cycles & Growth in the Ophthalmology Sector
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Venture

Panel Participants:
Adnan Butt, Research Analyst – RBC Capital Markets
Caroline Corner, PhD, Managing Director, Senior Research Analyst – Cantor Fitzgerald
Philip Nadeau, PhD, Managing Director – Cowen & Company
David Nierengarten, PhD, Managing Director & Head, Healthcare Equity Research – Wedbush Securities
Yigal Nochomovitz, PhD, Director & SMid Cap Biotech Analyst – Citigroup
Joshua Schimmer, MD, Managing Director & Biotechnology Research Analyst – Piper Jaffray & Co.

5:20 – 6:00 pm Master of the Universe
Moderated By:
James V. Mazzo, Chairman & CEO – AcuFocus, Executive Chairman – Neurotech

Panel Participants:
Jeff George, President & Global Head – Alcon
Dr. Ari Kellen, EVP, Company Group Chairman – Valeant/Bausch+Lomb
William J. Link, PhD, Managing Director – Versant Ventures
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec AG
Brent Saunders, President & CEO – Allergan
Naveed Shams, MD, PhD, Chief Scientific Officer, President & CEO – Santen

6:00 – 6:05 pm Wrap Up & Closing Comments
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
6:05 – 7:00 pm Networking Reception